Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

被引：1596
作者：
Mawuenyega, Kwasi G. [1 ]
Sigurdson, Wendy [1 ,2 ]
Ovod, Vitaliy [1 ]
Munsell, Ling [1 ]
Kasten, Tom [1 ]
Morris, John C. [1 ,2 ,3 ]
Yarasheski, Kevin E. [4 ]
Bateman, Randall J. [1 ,2 ,5 ]
机构：
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA
来源：
SCIENCE | 2010年 / 330卷 / 6012期
关键词：
IN-VIVO;
D O I：
10.1126/science.1197623
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：1774 / 1774
页数：1
相关论文
共 7 条
  • [1] Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
    Bateman, Randall J.
    Munsell, Ling Y.
    Morris, John C.
    Swarm, Robert
    Yarasheski, Kevin E.
    Holtzman, David M.
    [J]. NATURE MEDICINE, 2006, 12 (07) : 856 - 861
  • [2] A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System
    Bateman, Randall J.
    Siemers, Eric R.
    Mawuenyega, Kwasi G.
    Wen, Guolin
    Browning, Karen R.
    Sigurdson, Wendy C.
    Yarasheski, Kevin E.
    Friedrich, Stuart W.
    DeMattos, Ronald B.
    May, Patrick C.
    Paul, Steven M.
    Holtzman, David M.
    [J]. ANNALS OF NEUROLOGY, 2009, 66 (01) : 48 - 54
  • [3] Drug therapy - Alzheimer's disease
    Cummings, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) : 56 - 67
  • [4] ApoE and clusterin cooperatively suppress Aβ levels and deposition:: Evidence that ApoE regulates extracellular Aβ metabolism in vivo
    DeMattos, RB
    Cirrito, JR
    Parsadanian, M
    May, PC
    O'Dell, MA
    Taylor, JW
    Harmony, JAK
    Aronow, BJ
    Bales, KR
    Paul, SM
    Holtzman, DM
    [J]. NEURON, 2004, 41 (02) : 193 - 202
  • [5] Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience .15.
    Ellis, RJ
    Olichney, JM
    Thal, LJ
    Mirra, SS
    Morris, JC
    Beekly, D
    Heyman, A
    [J]. NEUROLOGY, 1996, 46 (06) : 1592 - 1596
  • [6] Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
    Hardy, J
    Selkoe, DJ
    [J]. SCIENCE, 2002, 297 (5580) : 353 - 356
  • [7] Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
    Scheuner, D
    Eckman, C
    Jensen, M
    Song, X
    Citron, M
    Suzuki, N
    Bird, TD
    Hardy, J
    Hutton, M
    Kukull, W
    Larson, E
    LevyLahad, E
    Viitanen, M
    Peskind, E
    Poorkaj, P
    Schellenberg, G
    Tanzi, R
    Wasco, W
    Lannfelt, L
    Selkoe, D
    Younkin, S
    [J]. NATURE MEDICINE, 1996, 2 (08) : 864 - 870
1